Cargando…
SP and KLF Transcription Factors in Cancer Metabolism
Tumor development and progression depend on reprogramming of signaling pathways that regulate cell metabolism. Alterations to various metabolic pathways such as glycolysis, oxidative phosphorylation, lipid metabolism, and hexosamine biosynthesis pathway are crucial to sustain increased redox, bioene...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456310/ https://www.ncbi.nlm.nih.gov/pubmed/36077352 http://dx.doi.org/10.3390/ijms23179956 |
_version_ | 1784785784695422976 |
---|---|
author | Orzechowska-Licari, Emilia J. LaComb, Joseph F. Mojumdar, Aisharja Bialkowska, Agnieszka B. |
author_facet | Orzechowska-Licari, Emilia J. LaComb, Joseph F. Mojumdar, Aisharja Bialkowska, Agnieszka B. |
author_sort | Orzechowska-Licari, Emilia J. |
collection | PubMed |
description | Tumor development and progression depend on reprogramming of signaling pathways that regulate cell metabolism. Alterations to various metabolic pathways such as glycolysis, oxidative phosphorylation, lipid metabolism, and hexosamine biosynthesis pathway are crucial to sustain increased redox, bioenergetic, and biosynthesis demands of a tumor cell. Transcription factors (oncogenes and tumor suppressors) play crucial roles in modulating these alterations, and their functions are tethered to major metabolic pathways under homeostatic conditions and disease initiation and advancement. Specificity proteins (SPs) and Krüppel-like factors (KLFs) are closely related transcription factors characterized by three highly conserved zinc fingers domains that interact with DNA. Studies have demonstrated that SP and KLF transcription factors are expressed in various tissues and regulate diverse processes such as proliferation, differentiation, apoptosis, inflammation, and tumorigenesis. This review highlights the role of SP and KLF transcription factors in the metabolism of various cancers and their impact on tumorigenesis. A better understanding of the role and underlying mechanisms governing the metabolic changes during tumorigenesis could provide new therapeutic opportunities for cancer treatment. |
format | Online Article Text |
id | pubmed-9456310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94563102022-09-09 SP and KLF Transcription Factors in Cancer Metabolism Orzechowska-Licari, Emilia J. LaComb, Joseph F. Mojumdar, Aisharja Bialkowska, Agnieszka B. Int J Mol Sci Review Tumor development and progression depend on reprogramming of signaling pathways that regulate cell metabolism. Alterations to various metabolic pathways such as glycolysis, oxidative phosphorylation, lipid metabolism, and hexosamine biosynthesis pathway are crucial to sustain increased redox, bioenergetic, and biosynthesis demands of a tumor cell. Transcription factors (oncogenes and tumor suppressors) play crucial roles in modulating these alterations, and their functions are tethered to major metabolic pathways under homeostatic conditions and disease initiation and advancement. Specificity proteins (SPs) and Krüppel-like factors (KLFs) are closely related transcription factors characterized by three highly conserved zinc fingers domains that interact with DNA. Studies have demonstrated that SP and KLF transcription factors are expressed in various tissues and regulate diverse processes such as proliferation, differentiation, apoptosis, inflammation, and tumorigenesis. This review highlights the role of SP and KLF transcription factors in the metabolism of various cancers and their impact on tumorigenesis. A better understanding of the role and underlying mechanisms governing the metabolic changes during tumorigenesis could provide new therapeutic opportunities for cancer treatment. MDPI 2022-09-01 /pmc/articles/PMC9456310/ /pubmed/36077352 http://dx.doi.org/10.3390/ijms23179956 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Orzechowska-Licari, Emilia J. LaComb, Joseph F. Mojumdar, Aisharja Bialkowska, Agnieszka B. SP and KLF Transcription Factors in Cancer Metabolism |
title | SP and KLF Transcription Factors in Cancer Metabolism |
title_full | SP and KLF Transcription Factors in Cancer Metabolism |
title_fullStr | SP and KLF Transcription Factors in Cancer Metabolism |
title_full_unstemmed | SP and KLF Transcription Factors in Cancer Metabolism |
title_short | SP and KLF Transcription Factors in Cancer Metabolism |
title_sort | sp and klf transcription factors in cancer metabolism |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456310/ https://www.ncbi.nlm.nih.gov/pubmed/36077352 http://dx.doi.org/10.3390/ijms23179956 |
work_keys_str_mv | AT orzechowskalicariemiliaj spandklftranscriptionfactorsincancermetabolism AT lacombjosephf spandklftranscriptionfactorsincancermetabolism AT mojumdaraisharja spandklftranscriptionfactorsincancermetabolism AT bialkowskaagnieszkab spandklftranscriptionfactorsincancermetabolism |